May 17, 2021

CAR-NKT Cell Therapy Can Induce Complete Remissions in Pediatric Neuroblastoma

Posted by in category: biotech/medical

CAR natural killer T cells that co-express GD2 and interleukin-15 were found to be safe and to demonstrate evidence of in vivo expansion and localization to metastatic sites in patients with stage IV relapsed/refractory neuroblastoma.

Comments are closed.